Related Experiment Video
Updated: Mar 2, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
SU-D-217BCD-04: How Do We Know How Low Can We Go in Lung Cancer Screening CT?
This study shows that a radiation dose level of 25% of standard chest CT provides acceptable image quality for lung cancer screening. This dose reduction is safe and effective for early detection of lung cancer.
Area of Science:
- Radiology
- Medical Imaging
- Oncology
Background:
- Lung cancer screening with low-dose computed tomography (CT) aims to reduce mortality.
- Optimizing radiation dose is crucial to minimize risks associated with CT scans.
- Establishing acceptable dose levels ensures effective screening without unnecessary radiation exposure.
Purpose of the Study:
- To develop and demonstrate a method for determining the acceptable radiation dose for lung cancer screening CT.
- To evaluate image quality at various reduced radiation dose levels for lung cancer screening.
Main Methods:
- Twenty patients undergoing routine chest CT were included.
- Noise insertion software simulated reduced radiation doses (12.5%, 25%, 50% of original).
- Three thoracic radiologists blindly assessed image quality for diagnostic and screening tasks using a 5-point scale.
Main Results:
- Lung cancer screening CT achieved 100% acceptable image quality at 25% of the original dose.
- Routine diagnostic chest CT required higher doses for acceptable image quality, especially for soft tissue evaluation.
- Acceptable image quality for screening was maintained even at 12.5% of the original dose for lung tissue.
Conclusions:
- A radiation dose of 25% of that used for routine diagnostic chest CT is sufficient for lung cancer screening.
- This fourfold dose reduction is comparable to doses used in the National Lung Screening Trial (NLST).
- The findings support the use of significantly reduced radiation doses for effective lung cancer screening CT.
More Related Videos
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
11:31Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
Published on: May 20, 2016